FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
FDA Approves New Treatment
Connected entities
organizationBlood Cancer Patients. TheorganizationCellsorganizationDrug AdministrationorganizationGVHDorganizationPrevent Serious ComplicationsorganizationTregorganizationTREGZI
Appears in 1 topic(s)